Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus Doubal

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2017
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combinationGordon W Blair, Jason P Appleton, Zhe Kang Law, et al.
Eclinicalmedicine|July 19, 2019
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trialGordon W Blair, Jason P Appleton, Katie Flaherty, et al.
Journal of the American Heart Association|January 30, 2026
Stroke, Small-Vessel Disease, and Occupation: Systematic Review and Data AnalysisThomas Zhang, Una Clancy, Ayush Singh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 3, 2023
Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel diseaseSalvatore Rudilosso, Michael S Stringer, Michael Thrippleton, et al.
Neurology|October 24, 2024
Prevalence and Clinical Implications of Hemosiderin Deposits in Recent Small Subcortical InfarctsYu-Yuan Xu, Francesca M Chappell, Maria Del C Valdés Hernández, et al.
Journal of the Neurological Sciences|July 27, 2023
Paranasal sinuses opacification on magnetic resonance imaging in relation to brain health in sporadic small vessel disease - Systematic review and pilot analysisAlba Sáenz de Villaverde Cortabarría, Jun-Fang Zhang, Maria Del C Valdés Hernández, et al.
Neurology|May 23, 2022
Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel DiseaseSalvatore Rudilosso, Ernest Chui, Michael S Stringer, et al.
European Stroke Journal|February 21, 2024
European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokeJoanna M Wardlaw, Hugues Chabriat, Frank-Erik de Leeuw, et al.
Neurology|July 4, 2020
Accuracy of identifying incident stroke cases from linked health care data in UK BiobankKristiina Rannikmäe, Kenneth Ngoh, Kathryn Bush, et al.
European Stroke Journal|April 5, 2021
Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: ProtocolJoanna M Wardlaw, Fergus Doubal, Rosalind Brown, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2017
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combinationGordon W Blair, Jason P Appleton, Zhe Kang Law, et al.
Eclinicalmedicine|July 19, 2019
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trialGordon W Blair, Jason P Appleton, Katie Flaherty, et al.
Journal of the American Heart Association|January 30, 2026
Stroke, Small-Vessel Disease, and Occupation: Systematic Review and Data AnalysisThomas Zhang, Una Clancy, Ayush Singh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 3, 2023
Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel diseaseSalvatore Rudilosso, Michael S Stringer, Michael Thrippleton, et al.
Neurology|October 24, 2024
Prevalence and Clinical Implications of Hemosiderin Deposits in Recent Small Subcortical InfarctsYu-Yuan Xu, Francesca M Chappell, Maria Del C Valdés Hernández, et al.
Journal of the Neurological Sciences|July 27, 2023
Paranasal sinuses opacification on magnetic resonance imaging in relation to brain health in sporadic small vessel disease - Systematic review and pilot analysisAlba Sáenz de Villaverde Cortabarría, Jun-Fang Zhang, Maria Del C Valdés Hernández, et al.
Neurology|May 23, 2022
Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel DiseaseSalvatore Rudilosso, Ernest Chui, Michael S Stringer, et al.
European Stroke Journal|February 21, 2024
European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokeJoanna M Wardlaw, Hugues Chabriat, Frank-Erik de Leeuw, et al.
Neurology|July 4, 2020
Accuracy of identifying incident stroke cases from linked health care data in UK BiobankKristiina Rannikmäe, Kenneth Ngoh, Kathryn Bush, et al.
European Stroke Journal|April 5, 2021
Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: ProtocolJoanna M Wardlaw, Fergus Doubal, Rosalind Brown, et al.
Pageof 6